European Journal of Cancer
Volume 37, Issue 18 , Pages 2365-2372 , December 2001

Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients

  • B. Cutuli

      Affiliations

    • Department of Radiotherapy, Centre Paul Strauss, Strasbourg, France
    • Corresponding Author InformationCorresponding author at: Polyclinique de Courlancy, 38 rue de Courlancy, 51100 Reims, France Tel.: +33-3-2684-0284; fax: +33-3-2684-7020
    • ,
  • C. Cohen-Solal-Le Nir

      Affiliations

    • Centre René-Huguenin, Saint Cloud, France
    • ,
  • B. De Lafontan

      Affiliations

    • Centre Claudius Regaud, Toulouse, France
    • ,
  • H. Mignotte

      Affiliations

    • Centre Léon Bérard, Lyon, France
    • ,
  • V. Fichet

      Affiliations

    • Institut Paoli-Calmettes, Marseille, France
    • ,
  • R. Fay

      Affiliations

    • MRC Statistics, Cernay Les Reims, France
    • ,
  • V. Servent

      Affiliations

    • Centre Oscar Lambret, Lille, France
    • ,
  • S. Giard

      Affiliations

    • Centre Oscar Lambret, Lille, France
    • ,
  • C. Charra-Brunaud

      Affiliations

    • Centre Alexis Vautrin, Vandoeuvre les Nancy, France
    • ,
  • H. Auvray

      Affiliations

    • Centre Jean Perrin, Clermont-Ferrand, France
    • ,
  • F. Penault-Llorca

      Affiliations

    • Centre Jean Perrin, Clermont-Ferrand, France
    • ,
  • J.-C. Charpentier

      Affiliations

    • MRC Statistics, Cernay Les Reims, France

Received 4 January 2001 ,Revised 17 August 2001 ,Accepted 30 August 2001.

References 

  1. Schwartz GF, Solin LJ, Olivotto IA, et al.  Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer. 2000;88:946–954
  2. Hwang ES, Esserman LJ. Management of ductal carcinoma in situ. Surg. Clin. North Am. 1999;79:1007–1030
  3. Lagios MD. Lagios experience. In:  Silverstein MF editors. Ductal Carcinoma In Situ of the Breast. Baltimore: Williams & Wilkins; 1997;p. 361–365
  4. Solin LJ, Yeh IT, Kurtz J, et al.  Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532–2542
  5. Silverstein MJ. Van Nuys experience by treatment. In:  Silverstein MJ editors. Ductal Carcinoma In Situ of the Breast. Baltimore: Williams & Wilkins; 1997;p. 443–447
  6. Fisher B, Digham J, Wolkmar N, et al.  Lumpectomy and radiation therapy fot the treatment of intraductal breast cancer (findings from National Surgical Adjuvant Breast and Bowel Project B-17). J. Clin. Oncol. 1998;16:441–452
  7. Fisher ER, Dignam J, Tan-Chiu E, et al.  Pathologic findings from National Surgical Adjuvant Breast Project (NSABP). Eight-year update of protocol B-17. Intraductal Carcinoma. Cancer. 1999;86:429–438
  8. Julien JP, Bijker N, Fentiman IS, et al.  Radiotherapy in breast-conservative treatment for ductal carcinoma in situ (first results of the EORTC randomized phase III trial 10853). Lancet. 2000;355:528–533
  9. Bijker N, Peterse JL, Duchateau L, et al.  Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ (analysis of European Organisation for Research and Treatment of Cancer trial 10853). J. Clin. Oncol. 2001;19:2263–2271
  10. Silverstein MJ, Lagios MD, Groshen S, et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. N. Engl. J. Med. 1999;340:1455–1461
  11. Holland R, Peterse JL, Millis RR, et al.  Ductal carcinoma in situ (a proposal for a new classification). Sem. Diag. Pathol. 1994;11:167–180
  12. Silverstein MJ, Poller DN, Waisman JR, et al.  Prognostic classification of breast ductal carcinoma in situ. Lancet. 1995;345:1154–1157
  13. Warnberg F, Nordgren H, Bergh J, Holmberg L. Ductal carcinoma in situ of the breast from a population-defined cohort (an evaluation of new histopathological classification systems). Eur. J. Cancer. 1999;15:714–720
  14. Zaugg K, Bodis S. Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?. Radiother. Oncol. 2000;55:95–99
  15. Recht A, Rutgers EJ, Fentiman IS, et al.  The fourth EORTC DCIS Consensus Meeting (Château Marquette, Heemskerk, The Netherlands, 23–24 January 1998). Conference Report. Eur. J. Cancer. 1998;34:1664–1669
  16. Rosai J. Borderline epithelial lesions of the breast. Am. J. Surg. Pathol. 1991;15:209–221
  17. van de Vijever MJ. Ductal carcinoma in situ of the breast: histological classification and genetic alterations. In Adjuvant Therapy of Primary Breast Cancer VI. Berlin, Springer, 1998.
  18. Fowble BL, Schultz DJ, Overmoyer B, et al.  The influence of young age on outcome in early stage breast cancer. Int. J. Radiat. Oncol. Biol. 1994;30:23–33
  19. de la Rochefordiere A, Asselain B, Campana F, et al.  Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993;341:1039–1043
  20. Vicini FA, Kestin LL, Goldstein NS, et al.  Impact of young age on outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy. J. Clin. Oncol. 2000;18:296–306
  21. Solin LJ, Fourquet A, Vicini FA, et al.  Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation; long-term outcome and prognostic significance of age and margin status. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:991–1002
  22. Fourquet A, Zafrani B, Campana F, et al.  Institut Curie experience. In:  Silverstein MJ editors. Ductal Carcinoma In Situ of The Breast. Baltimore: Williams & Wilkins; 1997;p. 391–397
  23. van Zee KJ, Liberman L, Samli B, et al.  Long-term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery. The effect of age. Cancer. 1999;86:1757–1767
  24. Horiot JC, Collette L, Fourquet A, et al. Impact of a boost dose of 16 Gy on local control in patients with early breast cancer: the EORTC ‘boost versus no boost’ trial. Eur J Cancer 2000, 36 (Suppl. 5), 593, 251 (abstr).
  25. Fowble B, Hanlon AL, Fein DA, et al.  Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int. J. Radiat. Oncol. Biol. Phys. 1997;38:949–957
  26. Silverstein MJ, Lagios MD, Martino S, et al.  Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J. Clin. Oncol. 1998;16:1367–1373
  27. Solin LJ, Kurtz J, Fourquet A, et al.  Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J. Clin. Oncol. 1996;14:754–763
  28. Vicini FA, Lacerna MD, Goldstein NS, et al.  Ductal carcinoma in situ detected in the mammographic era (an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy). Int. J. Radiat. Oncol. Biol. Phys. 1997;39:627–665
  29. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer. 1999;85:616–628
  30. Ringberg A, Idvall I, Ferno M, et al.  Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Eur. J. Surg. Oncol. 2000;26:444–451
  31. Tunon de Lara C, de Mascarel I, MacGrogan, et al. Analysis of 676 ductal carcinoma in situ ‘DCIS) of the breast from 1971 to 1995: diagnosis and treatment, the experience of one institute. Am J Clin Oncol, in press.
  32. Bonnier P, Body G, Bessenay F, et al.  Prognostic factors in ductal carcinoma in situ of the breast (results of a retrospective study of 575 cases). Eur. J. Obst. Gynecol. Repr. Biol. 1999;84:27–35
  33. Silverstein M. Ductal carcinoma in situ of the breast. Annu. Rev. Med. 2000;51:17–32
  34. Fisher B, Dignam J, Wolmark N, et al.  Tamoxifen in treatment of intraductal breast cancer (National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial). Lancet. 2000;353:1993–2000

☆ Presented in part at the 2nd European Breast Cancer Conference (EBCC) in Brussels on 28 September 2000.

PII: S0959-8049(01)00303-3

doi: 10.1016/S0959-8049(01)00303-3

European Journal of Cancer
Volume 37, Issue 18 , Pages 2365-2372 , December 2001

Article Tools

* Image Usage & Resolution